載入...
A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies
Options for targeted therapy of T-cell malignancies remain scarce. Recent clinical trials demonstrated that chimeric antigen receptors (CARs) can effectively redirect T lymphocytes to eradicate lymphoid malignancies of B-cell origin. However, T-lineage neoplasms remain a more challenging task for CA...
Na minha lista:
| 發表在: | Blood |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543231/ https://ncbi.nlm.nih.gov/pubmed/26056165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-02-629527 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|